Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia

Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia

Nafamostat mesylate, an apparent soi-disant panacea of sorts, is widely used to anticoagulate patients undergoing hemodialysis or cardiopulmonary bypass, mitigate the inflammatory response in patients diagnosed with acute pancreatitis, and reverse the coagulopathy of patients experiencing the common...

Full description

Bibliographic Details
Main Authors: George Zaki Ghali, Michael George Zaki Ghali
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Neural Regeneration Research
Subjects:
apoptosis; cerebrovascular; excitotoxicity; infarction; ischemia; nafamostat mesylate; necrosis; neuroprotection; serine protesae; subarachnoid hemorrhage
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=12;spage=2217;epage=2234;aulast=Ghali

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=12;spage=2217;epage=2234;aulast=Ghali

Similar Items